Transcription factor Foxp3 and its protein partners form a complex regulatory network

Nature Immunology

Volumn 13, Issue 10, 2012, Pages 1010-1019

  Rudra, Dipayan ^a   Deroos, Paul ^a   Chaudhry, Ashutosh ^a   Niec, Rachel E ^a   Arvey, Aaron ^a,b   Samstein, Robert M ^a   Leslie, Christina ^b   Shaffer, Scott A ^c,d   Goodlett, David R ^c   Rudensky, Alexander Y ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ASH21; TRANSCRIPTION FACTOR BCL 11B; TRANSCRIPTION FACTOR CBFBETA; TRANSCRIPTION FACTOR CHD4; TRANSCRIPTION FACTOR FOXP1; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR HDAC2; TRANSCRIPTION FACTOR LKZF3; TRANSCRIPTION FACTOR LSD1; TRANSCRIPTION FACTOR RCOR1; TRANSCRIPTION FACTOR SMARCA4; TRANSCRIPTION FACTOR SMARCA5; TRANSCRIPTION FACTOR SMARCC1; TRANSCRIPTION FACTOR SMARCE1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOTINYLATION; CD4+ CD25+ T LYMPHOCYTE; COMPLEX FORMATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REGULATORY T LYMPHOCYTE; TRANSCRIPTION REGULATION;

ANIMALS; CELL DIFFERENTIATION; FORKHEAD TRANSCRIPTION FACTORS; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; MICE; MICE, TRANSGENIC; PROTEIN STRUCTURE, TERTIARY; PROTEOMICS; T-LYMPHOCYTES, REGULATORY;

EID: 84866548843     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2402     Document Type: Article

References (49)

1. Josefowicz, S.Z., Lu, L.F., Rudensky, A.Y. & Regulatory, T. Cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531-564 (2012).
2. Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775-787 (2008). (Pubitemid 351707693)
3. Godfrey, V.L., Wilkinson, J.E. & Russell, L.B. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol. 138, 1379-1387 (1991).
4. Bennett, C.L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20-21 (2001). (Pubitemid 32044513)
5. Wildin, R.S. & Freitas, A. IPEX and FOXP3: clinical and research perspectives. J. Autoimmun. 25 (suppl.), 56-62 (2005). (Pubitemid 41728046)
6. Williams, L.M. & Rudensky, A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8, 277-284 (2007). (Pubitemid 46745377)
7. Marson, A. et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445, 931-935 (2007).
8. Zheng, Y. et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445, 936-940 (2007).
9. Gavin, M.A. et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445, 771-775 (2007). (Pubitemid 46279714)
10. Lin, W. et al. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8, 359-368 (2007). (Pubitemid 46745411)
11. van der Vliet, H.J. & Nieuwenhuis, E.E. IPEX as a result of mutations in FOXP3. Clin. Dev. Immunol. 2007, 89017 (2007).
12. Le Bras, S. & Geha, R.S. IPEX and the role of Foxp3 in the development and function of human Tregs. J. Clin. Invest. 116, 1473-1475 (2006).
13. Ziegler, S.F. FOXP3: of mice and men. Annu. Rev. Immunol. 24, 209-226 (2006).
14. Li, B. et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc. Natl. Acad. Sci. USA 104, 4571-4576 (2007). (Pubitemid 47186266)
15. Li, B. et al. FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease. Int. Immunol. 19, 825-835 (2007). (Pubitemid 47241891)
16. Chae, W.J., Henegariu, O., Lee, S.K. & Bothwell, A.L. The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells. Proc. Natl. Acad. Sci. USA 103, 9631-9636 (2006). (Pubitemid 43955876)
17. Wu, Y. et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126, 375-387 (2006). (Pubitemid 44092960)
18. + regulatory T cells. Science 325, 1142-1146 (2009).
19. Ono, M. et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446, 685-689 (2007). (Pubitemid 46606883)
20. Tao, R. et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13, 1299-1307 (2007). (Pubitemid 350073591)
21. Morkowski, S. et al. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates. J. Exp. Med. 182, 1403-1413 (1995).
22. de Boer, E. et al. Effcient biotinylation and single-step purifcation of tagged transcription factors in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA 100, 7480-7485 (2003). (Pubitemid 36759995)
23. Szymczak, A.L. et al. Correction of multi-gene defciency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat. Biotechnol. 22, 589-594 (2004). (Pubitemid 38585911)
24. Chen, Y.I. et al. Proteomic analysis of in vivo-assembled pre-mRNA splicing complexes expands the catalog of participating factors. Nucleic Acids Res. 35, 3928-3944 (2007).
25. Tyagi, A., Ryme, J., Brodin, D., Ostlund Farrants, A.K. & Visa, N. SWI/SNF associates with nascent pre-mRNPs and regulates alternative pre-mRNA processing. PLoS Genet. 5, e1000470 (2009).
26. Samstein, R.M. et al. Foxp3 exploits a preexistent enhancer landscape for regulatory T cell lineage specifcation. Cell (in the press).
27. Rudra, D. et al. Runx-CBFβ complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat. Immunol. 10, 1170-1177 (2009).
28. + regulatory T cells. Immunity 31, 609-620 (2009).
29. Ruan, Q. et al. Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. Immunity 31, 932-940 (2009).
30. Wang, Y., Su, M.A. & Wan, Y.Y. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 35, 337-348 (2011).
31. Wohlfert, E.A. et al. GATA3 controls Foxp3 regulatory T cell fate during infammation in mice. J. Clin. Invest. 121, 4503-4515 (2011).
32. Vanvalkenburgh, J. et al. Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of infammatory bowel disease. J. Exp. Med. 208, 2069-2081 (2011).
33. Mouly, E. et al. The Ets-1 transcription factor controls the development and function of natural regulatory T cells. J. Exp. Med. 207, 2113-2125 (2010).
34. Xu, L. et al. Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I. Immunity 33, 313-325 (2010).
35. Wei, G. et al. Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. Immunity 35, 299-311 (2011).
36. Zheng, Y. et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808-812 (2010).
37. Zhou, Z., Song, X., Li, B. & Greene, M.I. FOXP3 and its partners: structural and biochemical insights into the regulation of FOXP3 activity. Immunol. Res. 42, 19-28 (2008).
38. Zheng, Y. et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458, 351-356 (2009).
39. Dang, E.V. et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146, 772-784 (2011).
40. Darce, J. et al. An N-terminal mutation of the foxp3 transcription factor alleviates arthritis but exacerbates diabetes. Immunity 36, 731-741 (2012).
41. Bettini, M.L. et al. Loss of epigenetic modifcation driven by the foxp3 transcription factor leads to regulatory T cell insuffciency. Immunity 36, 717-730 (2012).
42. Klunker, S. et al. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J. Exp. Med. 206, 2701-2715 (2009).
43. + regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326, 986-991 (2009).
44. Langlais, D., Couture, C., Balsalobre, A. & Drouin, J. The Stat3/GR interaction code: predictive value of direct/indirect DNA recruitment for transcription outcome. Mol. Cell 47, 38-49 (2012).
45. Koch, M.A. et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 infammation. Nat. Immunol. 10, 595-602 (2009).
46. Pardo, M. et al. An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem Cell 6, 382-395 (2010).
47. Rubtsov, Y.P. et al. IL-10 produced by regulatory T cells contributes to their suppressor function by limiting infammation at environmental interfaces. Immunity 28, 546-558 (2008).
48. Pai, S.Y. et al. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity 19, 863-875 (2003).
49. Pear, W.S., Nolan, G.P., Scott, M.L. & Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396 (1993). (Pubitemid 23277674)